US Patent Issued to Armata Pharmaceuticals on April 7 for "Bacteriophage compositions for treating Pseudomonas infection" (American, Australian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,312, issued on April 7, was assigned to Armata Pharmaceuticals Inc. (Los Angeles).

"Bacteriophage compositions for treating Pseudomonas infection" was invented by Sebastien Lemire (Culver City, Calif.), Stacey Lynn Kolar (Los Angeles), Brian C. Varnum (Santa Monica, Calif.) and Sandra P. Morales (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to bacteriophages and compositions capable of infecting and killing Pseudomonas, and use of the same for treating Pseudomonas, e.g. Pseudomonas aeruginosa, bacterial infections."

The patent was filed on April 27, 2021, under Application No. 17/241,957.

*For further inform...